Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $140K 4,800 sh | Sep 22, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $86K 247 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $135K 388 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Dageville BenoitDirector | Tax withholding | F | $178K 535 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $155K 444 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $81K 231 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $149K 428 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Gage BrodieEVP & Chief Product & | Tax withholding | F | $154K 442 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | DiPerna DinoEVP & Chief R&D Officer | Tax withholding | F | $71K 204 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS | Grant or award | A | $1,477 66 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 5 | Beaulier Jonathan MeadChief Revenue Officer | Tax withholding | F | $23K 70 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $140K 1,600 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 5 | Dageville BenoitDirector | Tax withholding | F | $85K 256 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 4 | Offer OrChief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $271K 32.2K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 4 | Offer OrChief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $309K 37.5K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Brown HaydenDirector, President & CEO | Option exercise | M | — 17.7K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Coll Crespo BlasCHIEF MEDICAL OFFICER | Tax withholding · 10b5-1 plan | F | $124K 10.6K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion | C | — 62.5K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Voss Capital, LP10% Owner | In-the-money exercise | X | — 1,000 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Warren EricChief Commercial Officer | Option exercise · 10b5-1 plan | M | $98K 7,438 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 2 | Chuong JamesChief Financial Officer | Grant or award | A | — 6,374 sh | Sep 22, 2026 traded Sep 20, 2026 |
| 2 | Gessert EricaChief Financial Officer | Option exercise | M | — 8,433 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Brown HaydenDirector, President & CEO | Option exercise | M | — 28.7K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 2 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,700 sh | Sep 22, 2026 traded Sep 18, 2026 |
| 1 | Prahm JeremyChief Investment Officer | Open-market sale · 10b5-1 plan | SELL | $84K 6,000 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Coll Crespo BlasCHIEF MEDICAL OFFICER | Derivative conversion · 10b5-1 plan | C | — 12.0K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Slootman FrankDirector | Option exercise · 10b5-1 plan | M | — 102.8K sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Slootman FrankDirector | Option exercise · 10b5-1 plan | M | — 197.2K sh | Sep 22, 2026 traded Sep 18, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $596K 1,793 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $286K 860 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 0 | Warren EricChief Commercial Officer | Option exercise · 10b5-1 plan | M | — 7,438 sh | Sep 22, 2026 traded Sep 21, 2026 |
| 65 | Tan Anthony Ping YeowDirector, Chief Executive Officer | Open-market purchase | BUY | $29.88M 10.35M sh | Sep 21, 2026 traded Sep 21, 2026 |
| 48 | Kennedy David AlanChief Financial Officer | Open-market sale | SELL | $13.48M 23.0K sh | Sep 21, 2026 traded Sep 17, 2026 |
| 47 | Hungate Alexander CharlesDirector, President and COO | Open-market purchase | BUY | $867K 299.6K sh | Sep 21, 2026 traded Sep 21, 2026 |
| 47 | Knauf Mark HarryChief Financial Officer | Open-market purchase | BUY | $8,007 5,166 sh | Sep 21, 2026 traded Sep 16, 2026 |
| 46 | Attal AlainDirector | Open-market purchase | BUY | $402K 17.5K sh | Sep 21, 2026 traded Sep 21, 2026 |
| 45 | Rothberg Richard JGeneral Counsel & Secretary | Open-market sale | SELL | $2.33M 4,000 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 44 | Adcock Mary EllenExecutive Vice President | Open-market sale | SELL | $1.46M 24.1K sh | Sep 21, 2026 traded Sep 18, 2026 |
| 44 | Kuzoyan VaheDirector, President | Open-market sale | SELL | $180K 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |
| 44 | Mahdessian AraDirector, Chief Executive Officer | Open-market sale | SELL | $180K 3,148 sh | Sep 21, 2026 traded Sep 17, 2026 |